Effects of Linagliptin on Renal Endothelium Function in Patients with Type 2 Diabetes.
Phase of Trial: Phase III
Latest Information Update: 01 Sep 2016
At a glance
- Drugs Linagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 07 Jun 2017 Biomarkers information updated
- 01 Sep 2016 Results published in the Diabetologia
- 26 Mar 2014 Status changed from recruiting to completed, as per European Clinical Trials Database record.